Datadog Momentum Builds as Growth Expectations and AI Demand Keep Investors Focused
Datadog (DDOG) extended its strong 2026 run, with shares climbing about 7% as investors weighed rapid revenue growth, expanding AI workloads and bullish analyst coverage against an increasingly elevated valuation.
Datadog’s Rally Puts Growth and Valuation in Focus
Datadog shares pushed higher again, extending a rally that has nearly doubled the stock this year. The cloud monitoring and data analytics company has benefited from strong revenue growth, expanding multi-product adoption and increasing demand tied to AI and cloud workloads.
The latest move also comes as investors look toward Datadog’s next earnings report. Consensus estimates call for another quarter of double-digit earnings and revenue growth, while Wedbush assumed coverage with an Outperform rating and a $275 price target. The strength has pushed valuation back into focus as the stock trades at a substantial premium to the broader software industry.
Key Points
- Datadog shares climbed about 7%, extending a rally that has lifted the stock roughly 90% in 2026.
- Revenue rose 35.6% in the latest reported quarter, while expectations point to continued double-digit growth.
- AI demand and international expansion support the growth story, but Datadog trades at a significant valuation premium to its industry.
Why Is Datadog Stock Moving Higher?
Datadog has been one of the stronger software performers this year, with recent gains extending an already substantial advance.
The move comes against a backdrop of strong business growth. Datadog’s latest quarterly results showed revenue increasing more than 35% from a year earlier, while the company also exceeded earnings and revenue expectations.
Investor attention is now shifting toward the next earnings report. Expectations remain centered on continued double-digit growth, while recent analyst coverage has reinforced confidence in the company’s longer-term opportunity.
Analyst sentiment also remains broadly positive. Wedbush assumed coverage with an Outperform rating and a $275 target, while the broader analyst consensus cited in the supplied data carries an average target of $276.66.
AI and Global Expansion Add to Datadog’s Growth Story
AI is becoming an increasingly important part of Datadog’s business. The company serves hundreds of AI customers and has developed products covering areas such as GPU monitoring, AI agent observability and AI security.
As companies deploy more complex AI and cloud infrastructure, Datadog’s platform provides tools for monitoring applications, infrastructure, security and performance. That creates additional opportunities for customers to expand their use of the platform.
International expansion provides another growth channel. Markets outside North America already contribute meaningfully to revenue, and Datadog continues to expand its presence across Europe, Asia-Pacific and Latin America.
Competition remains significant, with Dynatrace (DT) expanding its AI observability capabilities and Cisco (CSCO) strengthening its position through Splunk and its broader enterprise portfolio.
Can Datadog’s Growth Support Its Valuation?
The rally has made valuation one of the clearest issues surrounding DDOG stock.
Datadog trades at a substantial premium to the broader software industry. One measure places its price-to-sales ratio above 23 times sales, compared with substantially lower multiples for the wider software group. Its forward price-to-earnings ratio is also near 98, versus about 20 for its cited industry average.
That premium reflects a company delivering rapid growth, but it also raises the importance of future execution. Datadog has beaten consensus earnings estimates in each of its past four quarters and also exceeded revenue expectations throughout that period.
The next earnings report will therefore provide another update on whether growth remains consistent with the expectations reflected in the stock. Beyond headline revenue and earnings, international adoption, AI-related workloads and continued platform expansion remain important parts of the company’s growth picture.
What It Means for Investors
Datadog’s recent price action reflects a combination of strong business growth and rising expectations. Revenue expanded more than 35% in the latest quarter, full-year guidance calls for roughly 30% growth, and AI workloads are creating additional use cases across the company’s observability and security platform.
At the same time, the stock’s sharp advance has widened the gap between Datadog’s valuation and industry averages. That makes upcoming financial results particularly relevant: investors are weighing continued growth against a share price that already carries a significant premium.
The result is a familiar dynamic for high-growth software companies. Datadog is expanding rapidly, but the stronger the stock performs, the more attention shifts from whether the business is growing to whether that growth can continue at a pace consistent with its valuation.
Conclusion
Datadog enters its next earnings cycle with substantial momentum. Strong revenue growth, expanding AI workloads, international adoption and positive analyst coverage have kept attention on the company as shares extend their 2026 advance.
The business continues to post rapid growth, while the stock’s premium valuation raises the importance of execution. The next earnings report will offer investors another look at whether Datadog’s operating performance continues to match the expectations now reflected in DDOG stock.
FAQs
Why is Datadog stock rising?
Datadog shares have gained momentum alongside strong revenue growth, expanding AI workloads and positive analyst coverage, with the stock up roughly 90% year to date.
How fast is Datadog growing?
Datadog reported quarterly revenue of $1.12 billion, up 35.6% year over year, while management expects full-year 2026 revenue of approximately $4.45 billion to $4.47 billion.
How important is AI to Datadog?
Datadog has more than 750 AI customers and offers products for areas including GPU monitoring, Agent Observability, AI Guard and Bits AI.
What is the analyst price target for Datadog?
The analyst consensus cited in the supplied data has an average price target of $276.66, while Wedbush assumed coverage with an Outperform rating and a $275 target.
Is Datadog trading at a premium valuation?
Yes. Datadog trades at valuation multiples substantially above the cited software industry averages, including a price-to-sales ratio above 23 times sales.
This article was created with AI assistance and reviewed by an editor. For details, please refer to our Terms of Use.
Go Beyond the Market Brief with Market Edge
Follow SharperTrades’ complete approach to trading and investing, combining active trade opportunities through Block Orders, long-term research through Stock Investor, and structured market education through the Swing Trading Masterclass. Try Market Edge for $19 your first month →
Explore Research with Stock Investor
Stock Investor is SharperTrades’ platform for long-term investing research and portfolio management. Members receive research reports, portfolio updates, conviction tracking, and in-depth analysis designed to support disciplined investment decisions.
Explore Active Trading & Income Strategies
Block Orders tracks institutional activity and highlights active trade setups and price behavior across long and short opportunities.
For options-focused traders, Essential Option Income provides a structured approach to options income strategies, while Pro Option Trader offers a broader range of options strategies and trade opportunities.
Think More Clearly with SteadyCapital
SteadyCapital is SharperTrades’ decision-support system for long-term investors, built around the SteadyCapital Method™. Review investment ideas, challenge assumptions, evaluate valuation and risk, compare companies, and think through important buy, hold, add, trim, or sell decisions before you act.
Risk Disclosure
All content is provided for educational purposes only and does not constitute investment advice. Trading involves risk, and past performance is not indicative of future results. Please review our full Risk Disclosure for additional information.